LIFE : Summary for aTyr Pharma, Inc. - Yahoo Finance

U.S. Markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.05-0.05 (-1.61%)
At close: 4:00 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.10
Bid2.95 x 200
Ask3.80 x 100
Day's Range2.90 - 3.10
52 Week Range2.48 - 10.93
Avg. Volume124,614
Market Cap72.34M
PE Ratio (TTM)-1.17
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire12 days ago

    aTyr Pharma Enters into $20 Million Credit Facility

    "We believe that managing our cost of capital and creating funding opportunities with premier partners enables us to create more value for our stockholders and deliver on our promise to patients," said John Mendlein, PhD, Chief Executive Officer of aTyr Pharma. "This funding agreement allows us to build upon our long-standing relationship with and provide additional financial support to aTyr Pharma's research and clinical development initiatives," said Anthony Flores, Director for Silicon Valley Bank.

  • aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session
    Zacks15 days ago

    aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session

    aTyr Pharma Inc. (LIFE) saw its shares rise almost 6% in the last trading session.

  • Associated Press19 days ago

    Atyr Pharma reports 3Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 58 cents. The company's shares closed at $3.15. A year ago, they were trading at $9.86. _____ This story was generated by Automated ...